Revisiting Rose: strategies for reducing coronary heart disease
about
Cardiovascular screening to reduce the burden from cardiovascular disease: microsimulation study to quantify policy optionsCardiovascular disease risk reduction in rural China: a clustered randomized controlled trial in ZhejiangWill cardiovascular disease prevention widen health inequalities?A systematic review of economic evaluations of interventions to tackle cardiovascular disease in low- and middle-income countriesIs the high-risk strategy to prevent cardiovascular disease equitable? A pharmacoepidemiological cohort study.Cardiovascular Disease Population Risk Tool (CVDPoRT): predictive algorithm for assessing CVD risk in the community setting. A study protocol.The cardio-protective diet.Effectiveness of community-wide and individual high-risk strategies to prevent diabetes: a modelling study.Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP).Assessing the impact of medication use on trends in major coronary risk factors in older British men: a cohort study.Predictive genetic testing for the identification of high-risk groups: a simulation study on the impact of predictive ability.Predicting Stroke Risk Based on Health Behaviours: Development of the Stroke Population Risk Tool (SPoRT)White coat hypertension is more risky than prehypertension: important role of arterial wave reflectionsPreventing type 2 diabetes in communities across the U.S.: the National Diabetes Prevention Program.Families of patients with premature coronary heart disease: an obvious but neglected target for primary prevention.Which population groups should be targeted for cardiovascular prevention? A modelling study based on the Norwegian Hordaland Health Study (HUSK).Measuring Burden of Unhealthy Behaviours Using a Multivariable Predictive Approach: Life Expectancy Lost in Canada Attributable to Smoking, Alcohol, Physical Inactivity, and Diet.Hypertension control in industrial employees: findings from SHIMSCO studyCan measurement of B-type natriuretic peptide levels improve cardiovascular disease prevention?The 2006 Canadian dyslipidemia guidelines will prevent more deaths while treating fewer people--but should they be further modified?Population health: challenges for science and society.The relative merits of population-based and targeted prevention strategiesModeling the impact of prevention policies on future diabetes prevalence in the United States: 2010-2030.Temporal shifts in cardiovascular risk factor distribution.Patient satisfaction with doctor-patient interaction and its association with modifiable cardiovascular risk factors among moderately-high risk patients in primary healthcare.An analysis of the management of cardiovascular risk factors in routine clinical practice in Italy: an overview of the main findings of the EFFECTUS study.The increasing burden of hypertension in Nigeria - can a dietary salt reduction strategy change the trend?Modes of delivery in preventive intervention studies: a rapid review.Review on cardiovascular risk prediction.Integrated preclinical cardiovascular prevention: a new paradigm to face growing challenges of cardiovascular disease.Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart.Cardiovascular risk reduction in hypertension: angiotensin-converting enzyme inhibitors, angiotensin receptor blockers. Where are we up to?Validation of a population coronary disease predictive system: the CASSANDRA model.Prevalence and control of hypertension in the general practice in Italy: updated analysis of a large database.Implementation of a comprehensive intervention for patients at high risk of cardiovascular disease in rural China: A pragmatic cluster randomized controlled trialPrevalence of 'borderline' values of cardiovascular risk factors in the clinical practice of general medicine in Italy: results of the BORDERLINE study.Modelling the potential impact of population-wide and targeted high-risk blood pressure-lowering strategies on cardiovascular disease in China.Statin prescribing according to gender, age and indication: what about the benefit-risk balance?Sick Populations and Sick Subpopulations: Reducing Disparities in Cardiovascular Disease Between Blacks and Whites in the United StatesCoronary heart disease and risk for cognitive impairment or dementia: Systematic review and meta-analysis.
P2860
Q24658434-1187A0CE-8177-424A-BD53-E93AB3994C1DQ33588766-1B728F44-82A4-43C3-8ED8-06A0E54BAA15Q33682023-A78B4B53-59D1-460A-B8A8-CD9FF37D8F8FQ34116368-05643F68-AC76-4F23-BE8E-0E67ED39C9CBQ34366183-9A1F51E5-62BF-49EF-B737-2E0B66650933Q34397159-EBFBB4DF-FB0D-442B-AEC2-A31158C812E3Q34530038-C52A4176-00D8-4A3F-9F18-DCE00B72E093Q34544605-3BEB3CB3-1AE5-4648-8F65-F6F0C16F3EFEQ34555488-87224F0D-2291-469B-82D2-2D83BDB06EE5Q35356996-D2DC46B8-1D87-4922-B041-B67AA995E4DAQ35565720-B37ABC5A-05CA-4CA7-B439-D364F9528D85Q35861221-52CA010E-57E9-41CB-86B8-A98323E09648Q35954805-398B9163-D750-482A-8315-B2A0A01789BAQ35964467-DE68783F-5D69-4490-A7F1-675EFBD1D6D6Q35980989-514B3AAE-76BC-4641-8AFA-D9CF2F9BC722Q36047855-AEA706B9-71A4-4B67-B2F0-29668D08A6E0Q36105034-5459352E-1F47-483D-8EB6-A15C22D4823DQ36144658-E1034107-6257-4C17-A93E-124E238E01F8Q37097127-422B18CD-A6B6-4B87-9B57-280158940AB0Q37101445-C34AEA19-D811-4F18-9B7F-6174343C8FBCQ37212063-39B7FA87-A6C7-4921-948E-949C1191DBAFQ37212186-40D137FD-1F97-4C0B-AC52-B518338BC41CQ37368036-CC9520A8-F380-4A64-B7C9-EF69904060D7Q37504533-D7F1CF4E-8E3F-4E4A-88EF-EF3E5869C6E9Q37661718-6508E123-4F81-40A7-A6CB-7A56F4589FA3Q37879657-34FB4547-4D28-4B99-A41A-C1316A37A664Q38134047-E6A205B3-97CD-431A-B520-BA99F2C0B8B6Q38211807-48117AE1-F4E9-4050-9446-B5C35CCD4C60Q38373055-488B2E86-49F6-42B1-8ECF-9276938C464DQ38430611-0A9520E0-7F99-442E-BC12-8321C360AC25Q38492555-CF5290D5-229A-47A8-B505-D72D3A93748EQ38770466-C7C42AC1-D248-42DE-94EC-480BAFB4664DQ39233353-569D63CA-BA0D-4D7C-A58F-F5E64EF75923Q39389575-F74F0001-C7F9-4841-A4E5-17DCF2E5B86CQ39584391-AE650C30-1354-40AF-BBDE-8411103B5C41Q39722466-4B891AC9-0A20-40C7-83B3-772A3A723AE2Q39875044-B1B603A3-17A8-4CC2-98B5-C521981368CDQ40455288-43D00F07-014E-4765-8C6E-83DAD5D39A66Q40690821-D9DF8FA4-AF71-4DDC-9FBF-9190EA00ED09Q41493209-FE6477AE-7CCD-4B9F-AB02-4F8296B4549F
P2860
Revisiting Rose: strategies for reducing coronary heart disease
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Revisiting Rose: strategies for reducing coronary heart disease
@ast
Revisiting Rose: strategies for reducing coronary heart disease
@en
Revisiting Rose: strategies for reducing coronary heart disease
@nl
type
label
Revisiting Rose: strategies for reducing coronary heart disease
@ast
Revisiting Rose: strategies for reducing coronary heart disease
@en
Revisiting Rose: strategies for reducing coronary heart disease
@nl
prefLabel
Revisiting Rose: strategies for reducing coronary heart disease
@ast
Revisiting Rose: strategies for reducing coronary heart disease
@en
Revisiting Rose: strategies for reducing coronary heart disease
@nl
P2093
P2860
P356
P1433
P1476
Revisiting Rose: strategies for reducing coronary heart disease
@en
P2093
Andreas Laupacis
Cameron A Mustard
David A Alter
Douglas G Manuel
Geoffrey M Anderson
Peter Tanuseputro
P2860
P304
P356
10.1136/BMJ.332.7542.659
P407
P577
2006-03-01T00:00:00Z